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Simian virus 40 (SV40) is a polyomavirus that originates 
from the rhesus macaque and was discovered in 1960 as a con-
taminant of human polio vaccines produced in monkey cells.1 
Recently, there has been considerable interest in the identifica-
tion of SV40 in human tumors, including malignant mesothe-
lioma (MM) and other rare tumors such as osteosarcoma, epen-
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Background: Simian virus 40 (SV40), a polyomavirus, was discovered as a contaminant of a hu-
man polio vaccine in the 1960s. It is known that malignant mesothelioma (MM) is associated with 
SV40, and that the virus works as a cofactor to the carcinogenetic effects of asbestos. However, 
the reports about the correlation between SV40 and MM have not been consistent. The purpose 
of this study is to identify SV40 in MM tissue in Korea through detection of SV40 protein and 
DNA. Methods: We analyzed 62 cases of available paraffin-blocks enrolled through the Korean 
Malignant Mesothelioma Surveillance System and performed immunohistochemistry for SV40 
protein and real-time polymerase chain reaction (PCR) for SV40 DNA. Results: Of 62 total cases, 
40 had disease involving the pleura (64.5%), and 29 (46.8%) were found to be of the epithelioid 
subtype. Immunostaining demonstrated that all examined tissues were negative for SV40 protein. 
Sufficient DNA was extracted for real-time PCR analysis from 36 cases. Quantitative PCR of 
these samples showed no increase in SV40 transcript compared to the negative controls. Con-
clusions: SV40 is not associated with the development of MM in Korea.
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dymoma, and choroid plexus tumors.2-6 Subsequently, it has 
been found that SV40 may play an important role in the etiolo-
gy of these tumors.2-6 However, SV40 was not detected in ma-
lignant lymphomas in Korean patients.7 Oncogenesis driven by 
SV40 is mediated by the large tumor antigen (T-Ag) oncopro-
tein, which is capable of transforming different types of cells in 
the absence of other viral genes.8,9 T-Ag induces DNA synthesis 
in host cells and prolongs the onset of the S-phase through the 
inhibition of tumor suppressor proteins p53 and Rb.8
MM is a rare and extremely aggressive neoplasm that arises 
from the serosal surfaces of pleural, peritoneal, and pericardial 
cavities and is very likely associated with amphibole asbestos 
exposure.10,11 In recent years, the incidence of MM has been 
gradually increasing in concert with industrial development 
and increased exposure to asbestos.12 However, only a small 
number of people who have been exposed to asbestos during 
their lifetime will develop MM.11 This suggests that SV40 may 
act as an independent carcinogenic agent or as a cofactor of as-
bestos to augment the risk of MM.13 Studies investigating the 
relation of SV40 to MM have been inconsistent and differ by 
geographical location.6
The incidence of MM varies according to geographic loca-
tion, and the highest incidence rates are reported from Austra-
lia, Belgium, and Great Britain.14 In Korea, the incidence of 
MM is very low compared with other developed countries, with 
only about one case per million in the last decade.14,15 However, 
the incidence is recently increasing. Korea has a higher propor-
tion of females (33.8%) among MM cases compared with other 
nations such as Canada (15.4%) or Italy (27.6%), and most of 
the patients are diagnosed when they are in their 50s, which is 
younger compared to cases in other countries.15 Although the 
majority of MM patients have had occupational (36.8%) and/or 
environmental (20.4%) asbestos exposure, the remaining pa-
tients (42.8%) had no known asbestos exposure.15
The role of SV40 in the oncogenesis of MM following asbes-
tos exposure has not yet been studied in a Korean population. 
The purpose of this study is to identify SV40 DNA and protein 
in tissues extracted from MM from a Korean population using 
quantitative polymerase chain reaction (PCR) and immunohis-
tochemical staining.
MATERIALS AND METHODS
Study population
Using the Korean Malignant Mesothelioma Surveillance 
(KMMS) tissue bank, 356 cases of MM that occurred between 
the years 2001 and 2009 were available. Of these, 62 formalin-
fixed and paraffin-embedded tissue tumor blocks were selected. 
The selection was based on the availability of adequate neoplas-
tic tissue within the paraffin blocks. Original diagnoses were 
based on morphological evaluation in the primary centers and 
confirmed by three expert pathologists. All cases were analyzed 
using an immunohistochemical panel (positive marker: cal-
retinin and/or D2-40, WT-1; negative marker: carcinoembry-
onic antigen). Each tumor slide was re-evaluated to verify the 
original diagnosis.
Immunohistochemistry
Detection of SV40 protein was performed by an automatic 
staining procedure using the Ventana Benchmark XT (Roche 
Diagnostics, Basel, Switzerland). The sections were deparaf-
finized, then pretreated with CC1 (Roche Diagnostics) for 60 
minutes at 42˚C. The sections were then washed with reaction 
buffer and incubated with anti-SV40 antibody (Cell Marque 
Corp., Rocklin, CA, USA) at a 1:100 dilution for 60 minutes at 
42˚C. Antibody detection was performed using the UltraView 
Universal DAB kit (Roche Diagnostics) according to the manu-
facturer’s recommendations. Finally, the slides were counter-
stained with hematoxylin (Roche Diagnostics) and mounted. 
As a positive control for SV40 sections from paraffin-embedded 
tissue, kidney tissue confirmed to contain polyomavirus was 
used (kindly provided by Professor Young-Mee Cho from the 
Department of Pathology, Asan Medical Center, Seoul, Korea). 
The negative controls were performed without the primary an-
tibody. 
DNA extraction from paraffin-embedded tissues
The paraffin-embedded tissue blocks were de-paraffinized us-
ing xylene. Briefly, the paraffin was removed by two extractions 
with 1 mL of xylene for 30 minutes and two with 0.5 mL of 
ethanol and subsequently dried at 37˚C. DNA was extracted 
using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, 
USA) according to the manufacturer’s instructions. Of the par-
affin-embedded tissues analyzed, sufficient DNA was only ex-
tracted from 36 samples.
β-actin PCR 
To ensure the quality of the extracted DNA, all samples were 
analyzed for the presence of the β-actin gene. DNA (200 ng) 
was amplified using a HotStar Taq Plus master mix kit (Qia-
gen). After a denaturing step of 15 minutes at 95˚C, 30 ampli-
fication cycles were performed. Each cycle consisted of 1 minute 
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at 94˚C, 30 seconds at 56°C, and 1 minute at 72˚C, followed by 
a final extension step of 5 minutes at 72˚C using β-actin (for-
ward 5´-CCT TCC TGG GAC TGG AGT CCT-3´ and reverse 
5´-GGA GCA ATG ATC TTG ATC TTC-3´) primers. 
SV40 quantitative PCR
A real-time PCR method (TaqMan) for SV40 was previously 
established which uses a primer pair and an oligonucleotide 
probe with the fluorescein reporter dye FAM attached to the 5´ 
end and a rhodamine dye (TAMRA) quencher linked to the 3´ 
end. A threshold cycle value (Ct) was calculated for each sample 
by determining the point at which the fluorescence exceeded 
the threshold limit chosen for the specific plate.
The real-time PCR assay used the forward primer 5´-CAC 
AGC ATG ACT CAA AAA ACT TAG CA-3´ and reverse pri-
mer 5´-GAC TCT CAA CAT TCT ACT CCT CCA AAA-3´ 
and the fluorogenic TaqMan probe 5´-ACC CCA AGG ACT 
TTC-3´. 
Negative controls (water) and positive controls (DNA from 
the HEK293T cell line) were included on each plate, and a stan-
dard curve (SV40 standard solutions) was produced from which 
the number of genomes in the samples could be calculated. The 
SV40 quantities used in the standards were 100,000, 10,000, 
1,000, 100, and 10 copies per 1 μL (i.e., per well). Thermal cy-
cling, fluorescence detection, and data analysis were performed 
on an ABI PRISM 7900 Sequence Detector (Applied Biosys-
tems, Foster City, CA, USA) using the software provided by the 
manufacturer.
The standard stock solution, plasmid pDRIVE, containing 
the SV40 genome was cultivated in medium, and the culture 
was purified according to the manufacturer’s instructions (Qia-
gen). The concentration of the plasmid solution was calculated 
using the absorbance at 260 nm.
Ethics statement
This study was approved by the Institutional Ethics Com-
mittee of Yonsei University, Wonju College of Medicine, Won-
ju, South Korea (IEC No. YWMR-12-4-033) and was in com-
pliance with the Helsinki Declaration.
RESULTS
Clinicopathological characteristics
The study included 38 (61.3%) males and 24 (38.7%) fe-
males between the ages of 34 and 79 years, with a mean age of 
60.2 years. The majority of patients developed MM when they 
were in their 50s, followed by patients over 70, patients in their 
60s, 40s and finally in their 30s (Fig. 1). Most cases of MM oc-
curred in the pleura (40 cases, 64.5%), followed by the perito-
neum (21 cases, 33.9%) and the pericardium (one case, 1.6%). 
With regard to histologic classification, the epithelioid type 
was the most common histologic type (29 cases, 46.8%), fol-
lowed by the biphasic (nine cases, 14.5%), sarcomatoid (six cas-
es, 9.7%), desmoplastic types (four cases, 6.5%), and other un-
determined variants (14 cases, 22.6%). The clinicopathological 
data are summarized in Table 1.
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Fig. 1. According to the age distribution, the majority of cases de-
veloped malignant mesothelioma when patients are in their 50s, 
followed by those over 70, those in their 60s, 40s and finally in their 
30s.
Table 1. Clinicopathologic characteristics of malignant mesothelio-
ma cases
Parameter n (%)
Mean age (range, yr) 60.2 (34-79)
Sex
Male
Female
38 (61.3)
24 (38.7)
Subtype
Epithelioid
Biphasic
Sarcomatous
Desmoplastic
Undeterminated
29 (46.8)
9 (14.5)
6 (9.7)
4 (6.5)
14 (22.6)
Site
Pleura
Peritoneum
Pericardium
40 (64.5)
21 (33.9)
1 (1.6)
Occupation
Asbestos exposure
None exposure
Unemployed
Unknown
11 (17.7)
11 (17.7)
1 (1.6)
39 (62.9)
Sampling method
Biopsy
Excision
EPP
12 (19.4)
34 (54.8)
16 (25.8)
EPP, extended pleuropneumonectomy.
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Table 2. Occupational history of malignant mesothelioma patients
Occupation
No. of 
patients
Comments
Construction   3 O ne patient also worked in copper 
pipe fabrication
Automobile repair   1
Shipbuilding repair   2
Environmental asbestos   1
Office worker   6 A dministrative, education office 
worker, Red Cross staff, teacher
Farmer   3
Trading   1
Housewife   4
Unemployed   1
Others   1 Production company
Unknown 39 Occupation history is not available
Total 62
A B
C D
Fig. 2. Immunohistochemical findings for simian virus 40 (SV40) antibody; (A) positive control tissue from kidney infected with SV40 shows a 
positive reaction, while tissue sections from malignant mesothelioma show a negative result for SV40 antibody (B, epithelioid type; C, bipha-
sic type; D, sarcomatoid type).
The occupational history was available for only 23 (37.1%) 
patients out of 62 patients, and among these, only 11 (17.7%) 
had a job that placed them at risk for asbestos exposure such as 
construction, automobile repair and production, shipbuilding 
and repair, or farming (Table 2).
Immunohistochemistry and real-time PCR findings
None of the 62 MM tissue samples studied showed a positive 
immunohistochemical staining for SV40, while the positive con-
trol kidney tissue for each slide was strongly positive (Fig. 2). 
Of the 36 samples that yielded sufficient DNA following ex-
traction and purification, real-time PCR analysis failed to show 
SV40 DNA amplification in any case. The mean cycle thresh-
old (Ct) value for the 36 available blocks was 34.133±1.440 
and was not significantly different from the negative control 
(positive control, 28.413±0.476; negative control, 34.437±  
0.160).
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DISCUSSION
The possible association between SV40 and MM has inspired 
much interest, especially after Carbone et al.16 reported the pres-
ence of SV40 in approximately 60% of mesotheliomas. Several 
subsequent studies have investigated the relation of mesothelio-
ma with SV40, but reported results have varied considerably. 
One study which investigated the presence of SV40 T-Ag in 18 
autopsied MM patients in Japan involved eight positive sam-
ples; however, none of these cases were likely to have received a 
contaminated polio vaccine due to their age.12 A recent review 
showed that the association of SV40 and MM was positive in 
only three cases out of 12.6 Another three studies showed that 
an average of 22% of tumor tissues were positive for SV40.6,10
A strong association between exposure to asbestos and the 
development of MM has long been established, but there exist 
cases with unclear etiologies that appear unrelated to asbestos 
exposure. MM is known to occur in only 10% to 20% of indi-
viduals heavily exposed to asbestos, and about 20% of patients 
lack a history of any exposure.17 In a case-control study, PCR 
analysis revealed the presence of SV40 DNA in eight of 19 cas-
es of MM among individuals exposed to asbestos, suggesting 
that SV40 may increase the risk of MM among patients exposed 
to asbestos.13
In hamsters, intrapleural injection of SV40 virus resulted in 
the development of MM in 100% of cases within two to six 
months.18 Additionally, a strong association between asbestos 
and SV40 was found among hamsters exposed to low levels of 
asbestos, as only the SV40-infected animals developed MM.19 
To understand the roles of both T-Ag and t-Ag in the develop-
ment of MM in hamsters, t-Ag mutant SV40 virus was injected 
intracardially into newborn hamsters, after which only one ani-
mal developed MM, while the majority developed histiocytic 
lymphomas.20 While T-Ag binds and deactivates tumor sup-
pressor proteins, t-Ag may play a key role in mesothelial cell 
transformation and may be necessary to complete inactivation 
and allow mesothelial cells to enter S phase.11,20
In humans, the role of SV40 in the development of MM is 
controversial. In total, more than 26 studies have identified 
SV40 in human mesotheliomas or other human tumors;11 how-
ever, many recent investigators have been unable to detect SV40 
in human mesothelioma tissues.10,11 In a study by Manfredi et 
al.,21 of 69 human MM tissues screened, none contained detect-
able SV40 T-Ag sequences, arguing against the role of SV40 in 
the development of human MMs.
In this study, no evidence of SV40 was found in any of the 
MM tissues examined, either by immunohistochemistry or real-
time PCR analysis. These results are consistent with those of 
most recent investigations. The discrepancy found among these 
different studies may suggest a possible role for geographical 
differences in the association between SV40 and MM. Alterna-
tively, contamination of laboratory plasmids may have led to 
false positive results in some cases.22
Occupational and environmental exposure to asbestos is the 
main causes of MM in Korea.15 Our results do not support an 
association between MM and SV40 or the proposed function of 
SV40 as a cofactor to asbestos carcinogenicity. If SV40 is indeed 
a cofactor for asbestos carcinogenicity, viral transcripts and pro-
teins would have been detectable in the cases examined in our 
study. 
We acknowledge some advantages and limitations of our 
study. We performed immunohistochemistry and real-time 
PCR separately to detect SV40 protein and DNA, respectively, 
in MM tissues. Frozen or fresh tissues are preferred for PCR de-
tection of viral DNA. However, acquiring frozen or fresh MM 
tissues is impractical due to the infrequency of MM. In addi-
tion, our sample size may not have been large enough to detect 
an association between SV40 and MM in the Korea.
In conclusion, no detection of SV40 in MM tissues suggests 
that the virus does not have a role in development of MM in 
Korea; therefore, a more active epidemiologic study for asbes-
tos-related occupational and environmental causes in MM pa-
tients is needed.
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